An Open-Label, Long-Term Extension Study to Evaluate the Safety of CB-03-01 Cream, 1% in Participants With Acne Vulgaris
NCT02682264
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
609
Enrollment
INDUSTRY
Sponsor class
Conditions
Acne Vulgaris
Interventions
DRUG:
CB-03-01 cream, 1%
Sponsor
Cassiopea SpA